| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 10/03/2006 | US7115605 Peptide deformylase inhibitors |
| 10/03/2006 | US7115601 spirocycle-substituted pyrimidinecarboxamides such as N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(1,4,9-triazaspiro[5.5]undec-9-yl)-4-pyrimidinecarboxamide for treating HIV infection and AIDS |
| 10/03/2006 | US7115600 Histamine-3 receptor modulators |
| 10/03/2006 | US7115599 Guanylate cyclase stimulant; cardiovascular disorders; thrombosis; antiischemic agents; sexual disorders; antiinflammatory agents; central nervous system disorders |
| 10/03/2006 | US7115596 Thiazole compounds as integrin receptor antagonists derivatives |
| 10/03/2006 | US7115589 Phosphorus-containing moietys; kinase inhibitors; improve balance of bone growth relative to bone resorption; inhibit PTH-induced bone resorption; cytotoxic or growth inhibitory effect on cancer cell lines |
| 10/03/2006 | US7115250 Heating erectile dysfunction drug to vaporize; cooling to form condensation aerosol; drug delivery |
| 10/03/2006 | CA2535728C Preparation of risperidone |
| 10/03/2006 | CA2277949C Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions |
| 10/03/2006 | CA2151507C Pharmaceutical composition containing bicyclic type compounds |
| 09/28/2006 | WO2006102642A1 Synthesis of pyrroloquinoline quinone (pqq) |
| 09/28/2006 | WO2006102500A2 Fluoroquinolonoquinolones and inkjet ink compositions comprising the same |
| 09/28/2006 | WO2006102093A1 Gaboxadol forms, compositions thereof, and related methods |
| 09/28/2006 | WO2006102079A1 N- [3- (1-amin0-5, 6, 7, 8-tetrahydro-2 , 4, 4b-triazafluoren-9-yl)-phenyl] benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
| 09/28/2006 | WO2006101603A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 09/28/2006 | WO2006101456A1 Bicyclic heterocycles hydroxamate compounds useful as histone deacetylase (hdac) inhibitors |
| 09/28/2006 | WO2006101455A1 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
| 09/28/2006 | WO2006101434A1 NOVEL TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLE DERIVATIVES AS CB1’ RECEPTOR LIGANDS |
| 09/28/2006 | WO2006100520A1 2,3-substituted fused pyrimidin-4(3h)-ones as vr1 antagonists |
| 09/28/2006 | WO2006100310A1 Heterobicylic inhibitors of hcv |
| 09/28/2006 | WO2006100305A2 Metal chelates of polyaminocarboxylic macrocyclic derivatives and use thereof in diagnostic imaging |
| 09/28/2006 | WO2006100255A1 Thioamide-substituted tricyclic benzimidazoles useful for the treatment of gastrointestinal diseases |
| 09/28/2006 | WO2006100226A1 Method for making 1-substituted 1h-imidazo[4,5-c]quinolin-4-amine compounds and intermediates therefor |
| 09/28/2006 | WO2006100119A1 Derivatives of imidazo (1,2-a) pyridine useful as medicaments for treating gastrointestinal diseases |
| 09/28/2006 | WO2006100095A1 Substituted carboxamides method for production and use thereof as tnf-alpha release inhibitors |
| 09/28/2006 | WO2006099972A1 Acetylenyl-pyrazolo-pvrimidine derivatives as mglur2 antagonists |
| 09/28/2006 | WO2006099681A1 Isoflavonoid dimers |
| 09/28/2006 | WO2005064008A9 Method and compositions for identifying anti-hiv therapeutic compounds |
| 09/28/2006 | US20060217554 Processes for producing pyrazoloacridone derivative and synthetic intermediate thereof |
| 09/28/2006 | US20060217426 Compound inhibiting in vivo phosphorous transport and medicine containing the same |
| 09/28/2006 | US20060217420 4-Ring imidazole derivatives as modulators of metabotropic glutamate receptor-5 |
| 09/28/2006 | US20060217418 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 09/28/2006 | US20060217413 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor |
| 09/28/2006 | US20060217412 Imidazo-fused oxazolo[4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 09/28/2006 | US20060217411 2-Phenyl- pyrazoloquinolin-3-ones and pyrazolo(thio)chromen-3-ones, e.g., N-[4-(6-Fluoro-3-oxo-3,5-dihydropyrazolo[4,3-c]quinolin-2-yl)-phenyl]-2-methyl-butyramide; used to treat rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosis and psoriasis |
| 09/28/2006 | US20060217410 Pre-organized tricyclic integrase inhibitor compounds |
| 09/28/2006 | US20060217409 Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 09/28/2006 | US20060217406 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents |
| 09/28/2006 | US20060217404 Pyridylpyrimidine derivatives as effective compounds against prion infections and prion diseases |
| 09/28/2006 | US20060217384 e.g. 1-((3-Phenyl-1,2,4-triazolo(3,4-a)phthalazines-6-yl)carbonyl)piperidine; high affinity to the benzodiazepine site of GABAA receptors; central nervous system (CNS) diseases such as depression, anxiety, and attention deficit disorder |
| 09/28/2006 | US20060217378 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety |
| 09/28/2006 | US20060217374 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 09/28/2006 | US20060217348 Pyrazolo[1,5-a] pyridines and medicines containing the same |
| 09/28/2006 | US20060217295 Neuroprotective macrocyclic compounds and methods for their use |
| 09/28/2006 | US20060216244 Delivery of compounds for the treatment of parkinson's through an inhalation route |
| 09/28/2006 | US20060216243 Delivery of Beta-Blockers Through An Inhalation Route |
| 09/28/2006 | CA2602541A1 Isoflavonoid dimers |
| 09/28/2006 | CA2602491A1 Synthesis of pyrroloquinoline quinone (pqq) |
| 09/28/2006 | CA2602470A1 Fluoroquinolonoquinolones and inkjet ink compositions comprising the same |
| 09/28/2006 | CA2602444A1 Acetylenyl-pyrazolo-pyrimidine derivatives as mglur2 antagonists |
| 09/28/2006 | CA2602395A1 2,3-substituted fused pyrimidin-4(3h)-ones as vr1 antagonists |
| 09/28/2006 | CA2602328A1 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
| 09/28/2006 | CA2602294A1 Heterobicylic inhibitors of hvc |
| 09/28/2006 | CA2602140A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 09/28/2006 | CA2601766A1 N- [3- (1-amin0-5, 6, 7, 8-tetrahydro-2 , 4, 4b-triazafluoren-9-yl)-phenyl] benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
| 09/28/2006 | CA2601388A1 Thioamide-substituted tricyclic benzimidazoles useful for the treatment of gastrointestinal diseases |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1704147A1 PYRROLO[2,3-b] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION COMPRISING THEM |
| 09/27/2006 | EP1704143A1 Malononitrile compound as pesticides |
| 09/27/2006 | EP1565445B1 Process for the preparation of imidazolyl compounds |
| 09/27/2006 | EP1404341B1 Active substance combination for medicamentous therapy of nicotine dependency |
| 09/27/2006 | EP1395590B1 Dihydropyrrolo¬1,2-a|indole and tetrahydropyrido¬1,2-a|indole derivatives as prostaglandin d2 receptor antagonists |
| 09/27/2006 | EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents |
| 09/27/2006 | CN1839135A Tricyclic delta-opioid modulators |
| 09/27/2006 | CN1839134A [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| 09/27/2006 | CN1839133A Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases |
| 09/27/2006 | CN1839132A N3-substituted imidazopyridine-derivatives as C-KIT inhibitors |
| 09/27/2006 | CN1838953A 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases |
| 09/27/2006 | CN1837207A Pirazino(aza)indole derivatives |
| 09/27/2006 | CN1837205A Process for the preparation of pyrazolopyridine tartrates |
| 09/27/2006 | CN1276921C Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1] octane, the preparation thereof and the application of same in therapeutics |
| 09/26/2006 | US7112677 1H-imidazo dimers |
| 09/26/2006 | US7112596 Prenylation inhibitors and methods of their synthesis and use |
| 09/26/2006 | US7112593 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient |
| 09/26/2006 | US7112592 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 09/26/2006 | US7112586 Substituted diamine derivatives useful as motilin antagonists |
| 09/21/2006 | WO2006099268A2 Cgrp receptor antagonists |
| 09/21/2006 | WO2006098912A1 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 09/21/2006 | WO2006097848A1 Hiv-1 virion maturation inhibitors, compositions and treatments using the same |
| 09/21/2006 | WO2006097808A1 Benzimidazolone derivatives as cb2 receptor ligands |
| 09/21/2006 | WO2006097625A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/21/2006 | WO2006097449A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations |
| 09/21/2006 | WO2006097340A1 1,7-naphthyridines as pde4 inhibitors |
| 09/21/2006 | WO2006076131A3 Chemical compounds |
| 09/21/2006 | WO2006072336A3 Radioactive metal complexes based on bispidine and derivatives thereof |
| 09/21/2006 | WO2006066913A3 Benzamide substituted imidazo- and pyrolo-pyridines as protein kinase inhibitors |
| 09/21/2006 | WO2006061373A3 Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
| 09/21/2006 | WO2005037207A3 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 09/21/2006 | US20060211728 Thalidomide analogs |
| 09/21/2006 | US20060211727 Novel compounds |
| 09/21/2006 | US20060211724 Hiv integrase inhibitors |
| 09/21/2006 | US20060211722 Amino cyclobutylamide modulators of chemokine receptor activity |
| 09/21/2006 | US20060211718 Deazaflavin compounds and methods of use thereof |
| 09/21/2006 | US20060211704 2,4-Disubstituted thiazolyl derivatives |
| 09/21/2006 | US20060211698 Bicyclic heteroaryl derivatives for treating viruses |
| 09/21/2006 | US20060211696 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 09/21/2006 | US20060211687 Potassium salt of an hiv integrase inhibitor |
| 09/21/2006 | US20060211678 e.g. 4-[4-(4-Fluoro-3-thiazol-5-ylphenylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; tyrosine and serine/threonine kinase inhibitor; anticarcinogenic agent |
| 09/21/2006 | US20060211677 5-lipoxygenase activating protein inhibitors; antiatherosclerotic, antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents |
| 09/21/2006 | US20060211675 Preventives/remedies for urinary disturbance |